Published on : Jun 22, 2017
Albany, New York, June 22, 2017: In the current phase, most of the parent's bank or store their baby's cord blood because it is rich in a particular type of stem cell. These stem cells are currently utilized in a variety of treatments for life-threatening and weakening diseases, thus the market is gaining huge momentum across the world. Considering this growth in the market, a study titled “Umbilical Cord Blood Banking Market- Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017-2025” has been recently published to the online repository of Market Research Hub (MRH). This report examines the current as well as future prospects of the market globally. In terms of geography, the research study focuses on five key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Additionally, the report also provides with market size and forecast for major countries in the respective regions.
In recent years, vast advancements in cord blood processing and storage technologies, increased awareness about stem cell therapy, and rise in applications of cord blood cells for treatment of various diseases is also propelling the market growth. Looking to these factors, analysts anticipates that the global umbilical cord blood banking market will increase at an 11.4% CAGR from 2017 to 2025. At this pace, the market is likely to reach a value of US$8,178.1 mn in 2025 which was pegged at US$3,124.4 mn in 2016.
Initially, this report includes a comprehensive executive summary, along with a market snapshot providing overall information about different segments and sub-segments considered within the scope of the study. Umbilical cord blood (UCB) is collected from the umbilical cord of a neonatal baby and also retrieved from the placenta after delivery. It has been analyzed that Umbilical cord blood is a rich source of primitive hematopoietic stem cells. Therefore, it has a strong regenerative potential for stem cell-based therapy for the treatment of non-hematological and hematological diseases. Umbilical cord blood is also used as an alternative to bone marrow treatment. As per the findings, the North America market is expected to exhibit strong growth in the next few years due to the increasing demand for stem cell research and public awareness about cord blood banking.
Furthermore, the study provides the overall information and data analysis of the global umbilical cord blood banking market with respect to the leading market segments which are based on type of storage, major application segment, end-user and geographies. Based on storage type, it covers public cord blood banks and private cord blood banks. Based on applications, the market has been categorized into Cancers, Immune Disorders, Metabolic Disorders, Blood Disorders and Osteopetrosis.
Later, the report also profiles key players operating in the umbilical cord blood banking market which are CBR Systems, Inc., ViaCord Inc., StemCyte Inc., China Cord Blood Corporation, Cryo-Cell International, Inc., Cryo-Save AG, Cordlife Group Ltd., Cord Blood America, Inc., Vita 34 AG, LifeCell, and other prominent companies.
Click here to get more info with TOC in a PDF Format : http://www.marketresearchhub.com/enquiry.php?type=S&repid=1166452
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com